In 2025, the annual Smartpharma® Awards ceremony took place in Moscow. The drug TRIAZAVIRIN® was named one of the top three winners in the category Domestic Oral Antiviral Drug for Influenza and Other ARVIs.
Smartpharma® Awards 2025 marked the 8th edition of this prestigious pharmaceutical event, where winners are selected exclusively by pharmacy professionals. This year, pharmacists selected the best candidates from over 80 nominees based on their professional experience and interactions with clients. The award unites more than 28,000 pharmaceutical workers.
TRIAZAVIRIN® demonstrates outstanding recognition among the medical community and consumers. Marketed for a decade, this drug remains the first representative of a new class of antiviral agents.